CIDRAP newsletters options
"If countries are serious about opening up, they must be serious about suppressing transmission and saving lives."
A new paper in Open Forum Infectious Diseases lays out some of the lessons learned from cases of antibiotic-resistant infections treated with bacteriophage therapy.
US counties with large declines in cell phone activity at workplaces, transit stations, and stores and concomitant increases in home activity during COVID-19 lockdowns had lower rates of coronavirus infections 5, 10, and 15 days later, according to a study published today in JAMA Internal Medicine.
The claim comes despite the fact that no major vaccine candidate has completed clinical trials.
In one study, 57% of patients got early antibiotics, but only 3.5% had a bacterial infection.
The first COVID-19 case has been detected in northern Syria's Al Hol refugee camp.
Scientists in New Delhi, India, report infections with worrisome multidrug-resistant Candida auris in 10 of 15 critically ill COVID-19 patients who also had candidemia over a span of several months, according to a report yesterday in Emerging Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
One more Ebola infection has been confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, raising the overall total to 107, the World Health Organization (WHO) African regional office said on Twitter today.
India has reported the world's highest daily total for about 3 weeks, but today its tally jumped by 75,000 cases.
One study finds that almost a quarter of pediatric patients had conjunctivitis, or pink eye.
CIDRAP Director Michael Osterholm, however, says the rapid test should not be used for diagnosis.
Individualized prescribing feedback and education in a telemedicine practice significantly decreased antibiotic prescribing rates for upper respiratory infection (URI) and bronchitis compared with education alone, US researchers reported yesterday in the Journal of General Internal Medicine.
A systematic review and meta-analysis of studies involving COVID-19 patients treated with hydroxychloroquine found that the antimalaria drug alone was not associated with reduced mortality in hospitalized patients, but when combined with the antibiotic azithromycin it was linked with significantly increased mortality, European researchers reported yesterday in Clinical Microbiology and Infection.
"This is atypical of any language I've seen coming from the CDC."
It only took 2 days for the global total to rise from 23 million to 24 million cases, and deaths have now topped 820,000.
Patients with metabolic syndrome had triple the risk of dying, one study showed.
Two more people in the Democratic Republic of the Congo (DRC) have tested positive for Ebola, raising the number of cases in the Equateur province outbreak to 104, the World Health Organization (WHO) African regional office said on Twitter today.
No new deaths were reported, keeping the fatality county at 44.
A new study by scientists in Massachusetts is highlighting the role that super-spreading events played in the spread of COVID-19 in the state.
Belgian and Dutch scientists confirm reinfections after recovery.
